NUTX - Nutex Health Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 6/10/2023
Current
3/31/202312/31/20229/30/20226/30/2022
Market Cap (intraday)
292.10M657.44M1.23B974.66M2.09B
Enterprise Value
541.15M890.38M1.46B1.17B2.08B
Trailing P/E
17.62N/A7.7513.9217.26
Forward P/E
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected)
N/AN/AN/AN/AN/A
Price/Sales (ttm)
1.532.925.393.066.18
Price/Book (mrq)
3.276.8711.181.8529.10
Enterprise Value/Revenue
2.7515.8127.1741.3535.83
Enterprise Value/EBITDA
-1.28-1.27k-243.60-2.71390.56

Yahoo Finance Plus Essential access required.

Learn more

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-92.30%
S&P500 52-Week Change 314.65%
52 Week High 37.1100
52 Week Low 30.4060
50-Day Moving Average 30.6247
200-Day Moving Average 31.2797

Share Statistics

Avg Vol (3 month) 32.06M
Avg Vol (10 day) 32.07M
Shares Outstanding 5656.56M
Implied Shares Outstanding 6N/A
Float 8327.67M
% Held by Insiders 149.41%
% Held by Institutions 14.85%
Shares Short (May 30, 2023) 412.8M
Short Ratio (May 30, 2023) 45.24
Short % of Float (May 30, 2023) 43.40%
Short % of Shares Outstanding (May 30, 2023) 41.95%
Shares Short (prior month Apr 27, 2023) 412.26M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Oct 31, 2019
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2022
Most Recent Quarter (mrq)Mar 30, 2023

Profitability

Profit Margin -229.71%
Operating Margin (ttm)-19.36%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)-308.51%

Income Statement

Revenue (ttm)196.5M
Revenue Per Share (ttm)0.30
Quarterly Revenue Growth (yoy)-28.80%
Gross Profit (ttm)116.4M
EBITDA -31.99M
Net Income Avi to Common (ttm)-451.37M
Diluted EPS (ttm)-0.6700
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)32.84M
Total Cash Per Share (mrq)0.05
Total Debt (mrq)281.88M
Total Debt/Equity (mrq)257.33
Current Ratio (mrq)1.85
Book Value Per Share (mrq)0.14

Cash Flow Statement

Operating Cash Flow (ttm)15.92M
Levered Free Cash Flow (ttm)N/A